Preclinical antiepileptic actions of selective serotonin reuptake inhibitors—Implications for clinical trial design
Abstract
Summary: Selective serotonin reuptake inhibitors (SSRIs) can reduce seizure frequency in humans, but no large‐scale clinical trials have been done to test the utility of SSRIs as potential antiepileptic drugs. This may be caused in part by a small number of reports on seizures triggered by SSRI treatment. The preclinical literature on SSRIs is somewhat conflicting, which is likely to contribute to the hesitance in accepting SSRIs as possible anticonvulsant drug therapy. A careful review of preclinical studies reveals that SSRIs appear to have region‐specific and seizure subtype–specific effects, with models of chronic partial epilepsy being more likely to respond than models of acute generalized seizures. Moreover, this preclinical profile is similar to that of clinical antiepileptic drugs. These observations suggest that SSRIs are promising antiepileptic agents, and that clinical trials may benefit from defining patient groups according to the underlying pathology.Keywords
This publication has 128 references indexed in Scilit:
- Seizure susceptibility is associated with altered protein expression of voltage-gated calcium channel subunits in inferior colliculus neurons of the genetically epilepsy-prone ratBrain Research, 2010
- Protein expression of small conductance calcium-activated potassium channels is altered in inferior colliculus neurons of the genetically epilepsy-prone ratBrain Research, 2009
- Serotonin depletion effects on the pilocarpine model of epilepsyEpilepsy Research, 2008
- The pilocarpine model of temporal lobe epilepsyJournal of Neuroscience Methods, 2008
- A anticonvulsive fraction from Scaptocosa raptoria (Araneae: Lycosidae) spider venomNeuroscience Letters, 2004
- Effects of piracetam alone and in combination with antiepileptic drugs in rodent seizure modelsJournal of Neural Transmission, 2004
- Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR)Life Sciences, 1995
- I. The genetically epilepsy-phone rat: An overview of seizure-prone characteristics and responsiveness to anticonvulsant drugsLife Sciences, 1986
- Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshockLife Sciences, 1978
- Effect of convulsant and anticonvulsant agents on level and metabolism of ?-aminobutyric acid in mouse brainNaunyn-Schmiedeberg's Archives of Pharmacology, 1977